Probiotic therapy of the irritable bowel syndrome;Probiotische Behandlung des Reizdarmsyndroms

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 8, 2011, Pages 371-375

  Enck, P ^a   Klosterhalfen, S ^a,b   Martens, U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

irritable bowel syndrome; metaanalysis; probiotics; review

Indexed keywords

ALOSETRON; CILANSETRON; CISAPRIDE; DOMPERIDONE; PLACEBO; PROBIOTIC AGENT; RENZAPRIDE; SEROTONIN UPTAKE INHIBITOR; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; TROSPIUM CHLORIDE;

IRRITABLE COLON; MEDICAL LITERATURE; MEDICAL RESEARCH; REVIEW;

ANIMALS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; IRRITABLE BOWEL SYNDROME; PROBIOTICS;

EID: 79951914194     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1272538     Document Type: Review

References (51)

1. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized (Pubitemid 41207833)
2. Brenner D M., Moeller M J., Chey W D., Schoenfeld P S. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009 104 1033-1049
3. Drouault-Holowacz S, Bieuvelet S, Burckel A et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008 32 147-152 (Pubitemid 351637577)
4. Enck P, Martens U. Der nächste Konsensus zum Reizdarmsyndrom muss interdisziplinär sein. Z Gastroenterol 2008 46 211-215 (Pubitemid 351326485)
5. Enck P, Zimmermann K, Menke G, Klosterhalfen, S. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Z Gastroenterol 2009 47 209-214
6. Enck P, Zimmermann K, Menke G et al. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome - a randomized controlled trial with primary care physicians. Neurogastroenterol Motil 2008 20 1103-1109
7. Enck P, Junne F, Klosterhalfen S, Zipfel S, Martens U. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol (in press)
8. Food and Agriculture Organisation, World Health Organisation. Evaluation of health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. FAO & WHO Expert Consultation Report 2001
9. Ford A C., Talley N J., Spiegel B M. et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008 337 a2313
10. Ford A C., Talley N J., Schoenfeld P S., Quigley E M., Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009 58 367-378
11. Ford A C., Brandt L J., Young C, Chey W D., Foxx-Orenstein A E., Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009 104 1831-1843
12. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989 66 365-378
13. Gade J, Thorn P. Paraghurt for patients with Irritable Bowel Syndrome. Scand J Prim Health Care 1989 7 23-26
14. Gawronska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007 25 177-184 (Pubitemid 46046374)
15. Guyonnet D, Chassany P, Ducrotte P et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007 26 475-486 (Pubitemid 47063138)
16. Haller D, Antoine J M., Bengmark S et al. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr 2010 140 690S-697S
17. Hoveyda N, Heneghan C, Mahtani K R. et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009 9 15
18. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991 88 90-97
19. Isolauri E, Kaila M, Mykkänen H, Ling W H., Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994 39 2595-2600
20. Jadad A R., Moore R A., Carroll D et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 1996 17 1-12 (Pubitemid 26120810)
21. Kajander K, Krogius-Kurikka L, Rinttila T et al. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther 2007 26 463-473 (Pubitemid 47063154)
22. Kim H J., Camilleri M, McKinzie S et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003 17 895-904 (Pubitemid 36459602)
23. Krammer H J., Kämper H, v Bünau R et al. Probiotische Arzneimitteltherapie mit E.coli Stamm Nissle 1917 (EcN): Ergebnisse einer prospektiven Datenerhebung mit 3807 Patienten. Z Gastroenterol 2006 44 651-656 (Pubitemid 44385516)
24. Kruis W, Schütz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997 11 853-858
25. Longstreth G F., Thompson W G., Chey W D. et al. Functional bowel disorders. Gastroenterology 2006 130 1480-1491
26. Manning A P., Thompson W G., Heaton K W., Morris A F. Towards positive diagnosis of the irritable bowel syndrome. Brit Med J 1978 2 653-654 (Pubitemid 9004104)
27. Martens U, Enck P, Zieseniss E. Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci 2010 8 Doc07
28. McFarland L V., Surawicz C M., Greenberg R N. et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994 271 1913-1918 (Pubitemid 24177098)
29. McFarland L V., Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008 14 2650-2661
30. McKernan D P., Fitzgerald P, Dinan T G., Cryan J F. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010 22 1029-1035
31. Metschnikoff I I. The prolongation of life - Optimistic studies. Heidelberg Springer 2004 Erstauflage: G.P.Putham's Sons, New York 1908
32. Moayyedi P, Ford A C., Talley N J. et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010 59 325-332
33. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001 13 1143-1147 (Pubitemid 33015878)
34. Nissle A. Über die Grundlagen einer neuen ursächlichen Bekämpfung der pathologischen Darmflora. Dtsch Med Wochenschr 1916 42 1181-1184
35. Nobaek S, Johansson M L., Molin G, Ahrné S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000 95 1231-1238 (Pubitemid 30263518)
36. Oksanen P J., Salminen S, Saxelin M et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990 22 53-56 (Pubitemid 20110832)
37. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005 128 541-551 (Pubitemid 40585355)
38. Parker R B. Probiotics, the other half of the antibiotic story. Anim Nutr Health 1974 29 4-8
39. Quartero A O., Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005 2 CD003460)
40. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2009 15 1548-1553
41. Rolfe R D. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000 130 Suppl 396S-402S (Pubitemid 30073758)
42. Schulze J, Sonnenborn U, Ölschläger T, Kruis W. Probiotika. Mikroökologie, Mikrobiologie, Qualität, Sicherheit und gesundheitliche Effekte. Kap. 2.2: Die Entwicklung des probiotischen Konzeptes. Stuttgart Thieme 2009
43. Simrén M, Ohman L, Olsson J et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment Pharmacol Ther 2010 31 218-227
44. Sinn D H., Song J H., Kim H J. et al. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008 53 2714-2718
45. Surawicz C M., Elmer G W., Speelman P et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989 96 981-988 (Pubitemid 19091110)
46. Tsuchiya J, Barreto R, Okura R et al. Single-blind follow up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis 2004 5 169-174 (Pubitemid 40028569)
47. Vandenplas Y, Benninga M. Probiotics and functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr 2009 48 Suppl 2 S107-109
48. Van der Waaij D. The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital-in-patients and those taking antibiotics. Antonie van Leeuwenhoek 1984 50 745-761 (Pubitemid 15175627)
49. Whorwell P J., Altringer L, Morel J et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006 101 1581-1590 (Pubitemid 43980633)
50. Wunderlich P F., Braun L, Fumagalli I et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989 17 333-338 (Pubitemid 19193537)
51. Zijdenbos I L., de Wit N J., van der Heijden G J., Rubin G, Quartero A O. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009 1 CD006442)